최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Journal of digestive cancer research, v.10 no.1, 2022년, pp.1 - 8
최수인 (인제대학교 의과대학 상계백병원 내과학교실)
The incidence of gastric neuroendocrine tumors (NET) has been increased with the improvement of endoscopy accessibility. The World Health Organization classified NET of low (G1), intermediate (G2), high (G3) grade and neuroendocrine carcinoma with poor differentiation by mitotic count and Ki-67 labe...
Modlin, I.M., Oberg, K., Chung, D.C., Jensen, R.T., de Herder, W.W., Thakker, R.V., Caplin, M., Delle Fave, G., Kaltsas, G.A., Krenning, E.P., Moss, S.F., Nilsson, O., Rindi, G., Salazar, R., Ruszniewski, P., Sundin, A.. Gastroenteropancreatic neuroendocrine tumours. The Lancet. Oncology, vol.9, no.1, 61-72.
Williams, E.D., Sandler, M.. THE CLASSIFICATION OF CARCINOID TUMOURS. The Lancet, vol.281, no.7275, 238-239.
Lloyd RV, Osamura RY, Klöppel G, Rosai J. WHO classification of tumours of endocrine organs. WHO classification of tumours of endocrine organs. 4th ed. Lyon: International Agency for Research on Cancer, 2017:1021-1044.
Klöppel, Günter. Oberndorfer and His Successors: From Carcinoid to Neuroendocrine Carcinoma. Endocrine pathology, vol.18, no.3, 141-144.
Yang, Zhen, Wang, WeiHua, Lu, JingFeng, Pan, Gaofeng, Pan, Zhiyu, Chen, Qian, Liu, Weiyan, Zhao, Yanping. Gastric Neuroendocrine Tumors (G-Nets): Incidence, Prognosis and Recent Trend Toward Improved Survival. Cellular physiology and biochemistry, vol.45, no.1, 389-396.
Boyce, Malcolm, Thomsen, Liv. Gastric neuroendocrine tumors: prevalence in Europe, USA, and Japan, and rationale for treatment with a gastrin/CCK2 receptor antagonist. Scandinavian journal of gastroenterology, vol.50, no.5, 550-559.
Modlin, Irvin M., Lye, Kevin D., Kidd, Mark. A 5-decade analysis of 13,715 carcinoid tumors. Cancer, vol.97, no.4, 934-959.
Strosberg, Jonathan R., Benson, Al B., Huynh, Lynn, Duh, Mei Sheng, Goldman, Jamie, Sahai, Vaibhav, Rademaker, Alfred W., Kulke, Matthew H.. Clinical Benefits of Above-Standard Dose of Octreotide LAR in Patients With Neuroendocrine Tumors for Control of Carcinoid Syndrome Symptoms: A Multicenter Retrospective Chart Review Study. The oncologist, vol.19, no.9, 930-936.
Rindi, Guido, Luinetti, Ombretta, Cornaggia, Matteo, Capella, Carlo, Solcia, Enrico. Three subtypes of gastric argyrophil carcinoid and the gastric neuroendocrine carcinoma: A clinicopathologic study. Gastroenterology, vol.104, no.4, 994-1006.
Gluckman, Craig R., Metz, David C.. Gastric Neuroendocrine Tumors (Carcinoids). Current gastroenterology reports, vol.21, no.4, 13-.
Cadiot, Guillaume, Laurent-Puig, Pierre, Thuille, Bénédicte, Lehy, Thérèse, Mignon, Michel, Olschwang, Sylviane. Is the multiple endocrine neoplasia type 1 gene a suppressor for fundic argyrophil tumors in the Zollinger-Ellison syndrome?. Gastroenterology, vol.105, no.2, 579-582.
Borch, Kurt, Ahrén, Bo, Ahlman, Håkan, Falkmer, Sture, Granérus, Göran, Grimelius, Lars. Gastric Carcinoids: Biologic Behavior and Prognosis After Differentiated Treatment in Relation to Type. Annals of surgery, vol.242, no.1, 64-73.
Thomas, Dimitrios, Tsolakis, Apostolos V, Grozinsky-Glasberg, Simona, Fraenkel, Merav, Alexandraki, Krystallenia, Sougioultzis, Stavros, Gross, David J, Kaltsas, Gregory. Long-term follow-up of a large series of patients with type 1 gastric carcinoid tumors: data from a multicenter study. European journal of endocrinology, vol.168, no.2, 185-193.
Tsolakis, Apostolos V, Ragkousi, Athanasia, Vujasinovic, Miroslav, Kaltsas, Gregory, Daskalakis, Kosmas. Gastric neuroendocrine neoplasms type 1: A systematic review and meta-analysis. World journal of gastroenterology : WJG, vol.25, no.35, 5376-5387.
Hosokawa, Osamu, Kaizaki, Yasuharu, Hattori, Masakazu, Douden, Kenji, Hayashi, Hiroyuki, Morishita, Minoru, Ohta, Kouji. Long-term follow up of patients with multiple gastric carcinoids associated with type A gastritis. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, vol.8, no.1, 42-46.
Gibril, Fathia, Schumann, Michael, Pace, Andrea, Jensen, Robert T.. Multiple Endocrine Neoplasia Type 1 and Zollinger-Ellison Syndrome: A Prospective Study of 107 Cases and Comparison With 1009 Cases From the Literature. Medicine, vol.83, no.1, 43-83.
Rindi, Guido, Bordi, Cesare, Rappel, Sigrid, La Rosa, Stefano, Stolte, Manfred, Solcia, Enrico. Gastric Carcinoids and Neuroendocrine Carcinomas: Pathogenesis, Pathology, and Behavior. World journal of surgery, vol.20, no.2, 168-172.
Ruszniewski, Philippe, Delle Fave, Gianfranco, Cadiot, Guillaume, Komminoth, Paul, Chung, Daniel, Kos-Kudla, Beata, Kianmanesh, Reza, Hochhauser, David, Arnold, Rudolf, Ahlman, Hakan, Pauwels, Stanislas, Kwekkeboom, Dik J., Rindi, Guido. Well-Differentiated Gastric Tumors/Carcinomas. Neuroendocrinology, vol.84, no.3, 158-164.
Norton, Jeffrey A., Melcher, Marc L., Gibril, Fathia, Jensen, Robert T.. Gastric carcinoid tumors in multiple endocrine neoplasia-1 patients with Zollinger-Ellison syndrome can be symptomatic, demonstrate aggressive growth, and require surgical treatment. Surgery, vol.136, no.6, 1267-1274.
Modlin, Irvin M, Lye, Kevin D, Kidd, Mark. A 50-Year Analysis of 562 Gastric Carcinoids: Small Tumor or Larger Problem?. The American journal of gastroenterology : official publication of the National Gastroenterological Association, vol.99, no.1, 23-32.
Rindi, G., Klöppel, G., Alhman, H., Caplin, M., Couvelard, A., de Herder, W. W., Erikssson, B., Falchetti, A., Falconi, M., Komminoth, P., Körner, M., Lopes, J. M., McNicol, A-M., Nilsson, O., Perren, A., Scarpa, A., Scoazec, J-Y., Wiedenmann, B.. TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system. Virchows Archiv : an international journal of pathology, vol.449, no.4, 395-401.
Nikou, George C., Angelopoulos, Theodoros P.. Current Concepts on Gastric Carcinoid Tumors. Gastroenterology Research and Practice, vol.2012, 287825-.
Hassan, Manal M., Phan, Alexandria, Li, Donghui, Dagohoy, Cecile G., Leary, Colleen, Yao, James C.. Risk factors associated with neuroendocrine tumors: A U.S.‐based case–control study. International journal of cancer: Journal international du cancer, vol.123, no.4, 867-873.
Kwon, Yong Hwan, Jeon, Seong Woo, Kim, Gwang Ha, Kim, Jin Il, Chung, Il-Kwun, Jee, Sam Ryong, Kim, Heung Up, Seo, Geom Seog, Baik, Gwang Ho, Choi, Kee Don, Moon, Jeong Seop. Long-term follow up of endoscopic resection for type 3 gastric NET. World journal of gastroenterology : WJG, vol.19, no.46, 8703-8708.
Modlin IM, Sandor A, Tang LH, Kidd M, Zelterman D. A 40-year analysis of 265 gastric carcinoids. Am J Gastroenterol 1997;92:633-638.
Gastric Carcinoid Tumour as a Cause of Severe Upper Gastrointestinal Haemorrhage. Endoscopy, vol.35, no.8, 716-716.
Rindi, Guido, Azzoni, Cinzia, Rosa, Stefano La, Klersy, Catherine, Paolotti, Donatella, Rappel, Sigrid, Stolte, Manfred, Capella, Carlo, Bordi, Cesare, Solcia, Enrico. ECL cell tumor and poorly differentiated endocrine carcinoma of the stomach: Prognostic evaluation by pathological analysis. Gastroenterology, vol.116, no.3, 532-542.
Shah, Manisha H., Goldner, Whitney S., Benson, Al B., Bergsland, Emily, Blaszkowsky, Lawrence S., Brock, Pamela, Chan, Jennifer, Das, Satya, Dickson, Paxton V., Fanta, Paul, Giordano, Thomas, Halfdanarson, Thorvardur R., Halperin, Daniel, He, Jin, Heaney, Anthony, Heslin, Martin J., Kandeel, Fouad, Kardan, Arash, Khan, Sajid A., Kuvshinoff, Boris W., Lieu, Christopher, Miller, Kimberly, Pillarisetty, Venu G., Reidy, Diane, Salgado, Sarimar Agosto, Shaheen, Shagufta, Soares, Heloisa P., Soulen, Michael C., Strosberg, Jonathan R., Sussman, Craig R., Trikalinos, Nikolaos A., Uboha, Nataliya A., Vijayvergia, Namrata, Wong, Terence, Lynn, Beth, Hochstetler, Cindy. Neuroendocrine and Adrenal Tumors, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network : JNCCN, vol.19, no.7, 839-868.
Singh, Simron, Law, Calvin. Chromogranin A: a sensitive biomarker for the detection and post-treatment monitoring of gastroenteropancreatic neuroendocrine tumors. Expert review of gastroenterology & hepatology, vol.6, no.3, 313-334.
Amin, Mahul B., Greene, Frederick L., Edge, Stephen B., Compton, Carolyn C., Gershenwald, Jeffrey E., Brookland, Robert K., Meyer, Laura, Gress, Donna M., Byrd, David R., Winchester, David P.. The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population‐based to a more “personalized” approach to cancer staging. CA: A Cancer Journal for Clinicians, vol.67, no.2, 93-99.
DIAS, Andre Roncon, AZEVEDO, Beatriz Camargo, ALBAN, Luciana Bastos Valente, YAGI, Osmar Kenji, RAMOS, Marcus Fernando Kodama Pertille, JACOB, Carlos Eduardo, BARCHI, Leandro Cardoso, CECCONELLO, Ivan, RIBEIRO-JR, Ulysses, ZILBERSTEIN, Bruno. GASTRIC NEUROENDOCRINE TUMOR: REVIEW AND UPDATE. Arquivos brasileiros de cirurgia digestiva : ABCD, vol.30, no.2, 150-154.
Soga, Jun. Early-stage carcinoids of the gastrointestinal tract : An analysis of 1914 reported cases. Cancer, vol.103, no.8, 1587-1595.
Pavel, Marianne, Baudin, Eric, Couvelard, Anne, Krenning, Eric, Öberg, Kjell, Steinmüller, Thomas, Anlauf, Martin, Wiedenmann, Bertram, Salazar, Ramon. ENETS Consensus Guidelines for the Management of Patients with Liver and Other Distant Metastases from Neuroendocrine Neoplasms of Foregut, Midgut, Hindgut, and Unknown Primary. Neuroendocrinology, vol.95, no.2, 157-176.
Berna, Marc J., Annibale, Bruno, Marignani, Massimo, Luong, Tu Vinh, Corleto, Vito, Pace, Andrea, Ito, Tetsuhide, Liewehr, David, Venzon, David J., Delle Fave, Gianfranco, Bordi, Cesare, Jensen, Robert T.. A Prospective Study of Gastric Carcinoids and Enterochromaffin-Like Cell Changes in Multiple Endocrine Neoplasia Type 1 and Zollinger-Ellison Syndrome: Identification of Risk Factors. The Journal of clinical endocrinology & metabolism, vol.93, no.5, 1582-1591.
Scherübl, H., Cadiot, G., Jensen, R. T., Rösch, T., Stölzel, U., Klöppel, G.. Neuroendocrine tumors of the stomach (gastric carcinoids) are on the rise: small tumors, small problems?. Endoscopy, vol.42, no.8, 664-671.
Kulke, Matthew H., Shah, Manisha H., Benson III, Al B., Bergsland, Emily, Berlin, Jordan D., Blaszkowsky, Lawrence S., Emerson, Lyska, Engstrom, Paul F., Fanta, Paul, Giordano, Thomas, Goldner, Whitney S., Halfdanarson, Thorvardur R., Heslin, Martin J., Kandeel, Fouad, Kunz, Pamela L., Kuvshinoff II, Boris W., Lieu, Christopher, Moley, Jeffrey F., Munene, Gitonga, Pillarisetty, Venu G., Saltz, Leonard, Sosa, Julie Ann, Strosberg, Jonathan R., Vauthey, Jean-Nicolas, Wolfgang, Christopher, Yao, James C., Burns, Jennifer, Freedman-Cass, Deborah. Neuroendocrine Tumors, Version 1.2015. Journal of the National Comprehensive Cancer Network : JNCCN, vol.13, no.1, 78-108.
Tsilimigras, Diamantis I., Hyer, J. Madison, Paredes, Anghela Z., Ejaz, Aslam, Cloyd, Jordan M., Beane, Joal D., Dillhoff, Mary, Tsung, Allan, Pawlik, Timothy M.. Resection of Primary Gastrointestinal Neuroendocrine Tumor Among Patients with Non-Resected Metastases Is Associated with Improved Survival: A SEER-Medicare Analysis. Journal of gastrointestinal surgery : official journal of the society for surgery of the alimentary tract, vol.25, no.9, 2368-2376.
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
저자가 APC(Article Processing Charge)를 지불한 논문에 한하여 자유로운 이용이 가능한, hybrid 저널에 출판된 논문
※ AI-Helper는 부적절한 답변을 할 수 있습니다.